CWRU licenses AIDS research to Diagnostic HYBRIDS
CLEVELAND, Ohio — Case Western Reserve University has licensed technology that gauges the success of AIDS treatment to Diagnostic HYBRIDS, an Athens, Ohio, medical company.
The innovation determines the drug resistance and disease strength of the virus, according to a press release. Researchers think the approach can be used to better develop a vaccine. It was created by Eric Arts, who works in the school’s department of infectious diseases.
Diagnostic HYBRIDS is headquartered in Athens but has a research lab in Cleveland. In June, both Diagnostic HYBRIDS and Case received a $5 million grant from Ohio’s Third Frontier fund to help the groups create products to address HIV, hepatitis and influenza.
Diagnostic HYBRIDS expects to next year start offering products and services to HIV physicians, drug companies and national laboratories, according to the release.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=73d709c2-5230-4907-b532-04745835f412)
[...] Visit original post by Chris Seper [...]
by HIV / AIDS Treatment » CWRU licenses AIDS research to Diagnostic HYBRIDS : MedCity News on Feb 3, 2009 at 11:04 am
[...] treatment and may help develop better vaccines for the virus. Diagnostic Hybrids Inc. is using Case technology to develop HIV-related tests in Cleveland and Athens, [...]
by Biotech heavily represented in Northeast Ohio innovation awards : MedCity News on Feb 16, 2009 at 4:28 pm
[...] Case Western Reserve University in Cleveland, Ohio, announced the licensing of technology that gauges the success of HIV and AIDS treatments to Diagnostic [...]
by FDA approves new Diagnostic HYBRIDS kit, completes respiratory virus line : MedCity News on Mar 18, 2009 at 4:07 pm
[...] instance, Diagnostic Hybrids has licensed technologies from Case Western Reserve University in Cleveland that gauges the success of AIDS treatments. In March, the U.S. Food & Drug [...]
by San Diego’s Quidel Corp. to buy Diagnostic Hybrids in Athens, Ohio, for $130 million : MedCity News on Jan 12, 2010 at 4:41 pm